4.7 Article

Evidence for a cross-talk between human neutrophils and Th17 cells

期刊

BLOOD
卷 115, 期 2, 页码 335-343

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-04-216085

关键词

-

资金

  1. Ministero dell'Istruzione
  2. dell'Universita e della Ricerca
  3. University of Verona
  4. Fondazione Cariverona, Associazione Italiana per la Ricerca sul Cancro [5839]
  5. Ente Cassa di Risparmio (Florence, Italy)
  6. EU [FP6-LSBH-CT-2006-018861]
  7. INNO-CHEM [FP6-LSHB-CT-2005-518167]
  8. Canadian Institutes of Health Research
  9. Associazione Italiana per la Ricerca sul Cancro

向作者/读者索取更多资源

Interleukin-17A (IL-17A) and IL-17F are 2 of several cytokines produced by T helper 17 cells (Th17), which are able to indirectly induce the recruitment of neutrophils. Recently, human Th17 cells have been phenotypically characterized and shown to express discrete chemokine receptors, including CCR2 and CCR6. Herein, we show that highly purified neutrophils cultured with interferon-gamma plus lipopolysaccharide produce the CCL2 and CCL20 chemokines, the known ligands of CCR2 and CCR6, respectively. Accordingly, supernatants from activated neutrophils induced chemotaxis of Th17 cells, which was greatly suppressed by anti-CCL20 and anti-CCL2 antibodies. We also discovered that activated Th17 cells could directly chemoattract neutrophils via the release of biologically active CXCL8. Consistent with this reciprocal recruitment, neutrophils and Th17 cells were found in gut tissue from Crohn disease and synovial fluid from rheumatoid arthritis patients. Finally, we report that, although human Th17 cells can directly interact with freshly isolated or preactivated neutrophils via granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interferon-gamma release, these latter cells cannot be activated by IL-17A and IL-17F, because of their lack of IL-17RC expression. Collectively, our results reveal a novel chemokine-dependent reciprocal cross-talk between neutrophils and Th17 cells, which may represent a useful target for the treatment of chronic inflammatory diseases. (Blood. 2010; 115: 335-343)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据